CLX vs IMDX · P/E 15, rev $7.10B vs rev $271.0K
The Clorox Company (CLX) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. IMDX currently screens at market cap $0.
Not investment advice. Open the CLX and IMDX stock pages for the full models.
Not investment advice.